$44 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SKLZ | SKILLZ INC | $28,408,000 | -58.7% | 22,909,859 | 0.0% | 64.55% | +2.1% | |
SURF | SURFACE ONCOLOGY INC | $4,831,000 | -44.2% | 2,945,453 | 0.0% | 10.98% | +37.8% | |
COGT | Sell | COGENT BIOSCIENCES INC | $4,211,000 | -38.7% | 466,832 | -49.1% | 9.57% | +51.5% |
SYBX | SYNLOGIC INC | $3,049,000 | -52.1% | 2,651,963 | 0.0% | 6.93% | +18.4% | |
SNAP | SNAP INCcl a | $1,972,000 | -63.5% | 150,160 | 0.0% | 4.48% | -9.8% | |
SPRO | SPERO THERAPEUTICS INC | $1,019,000 | -91.5% | 1,376,968 | 0.0% | 2.32% | -79.0% | |
NTLA | INTELLIA THERAPEUTICS INC | $518,000 | -28.7% | 10,000 | 0.0% | 1.18% | +75.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
INTELLIA THERAPEUTICS INC | 28 | Q3 2023 | 100.0% |
SNAP INC | 26 | Q3 2023 | 11.4% |
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 24.0% |
SYNLOGIC INC | 24 | Q2 2023 | 35.6% |
SURFACE ONCOLOGY INC | 21 | Q2 2023 | 33.3% |
SKILLZ INC | 12 | Q3 2023 | 87.5% |
UNUM THERAPEUTICS INC | 11 | Q3 2020 | 28.2% |
COGENT BIOSCIENCES INC | 7 | Q2 2022 | 9.6% |
CARBON BLACK INC | 6 | Q3 2019 | 7.8% |
COHERUS BIOSCIENCES INC | 1 | Q3 2023 | 18.1% |
View Atlas Venture Associates IX, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-08 |
13F-HR | 2023-01-31 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-01-27 |
13F-HR | 2021-11-04 |
13F-HR | 2021-08-11 |
View Atlas Venture Associates IX, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.